))
Ad Promo Review in Pharma - How Far is Too Far?
Manage episode 450491358 series 3506216
Content provided by Darshan Kulkarni. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Darshan Kulkarni or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Katie Graham and I discuss various aspects of FDA and FTC regulations, including ad promo, the Chevron decision, and the evolving role of compliance in the pharmaceutical industry.
Key topics include:
- What is Ad Promo?
- Chevron decision's influence on FDA/FTC
- Should administrative agencies cite letters?
- Can the FDA establish rules after someone challenges them?
- Uncertainty of Compliance White Space
- Is regulatory medical advice now just seen as a risk?
128 episodes
Share
